Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people starting Mounjaro notice a feeling of fullness or pressure in their ears, sometimes described as clogged ears, and wonder whether the medicine is to blame. Ear symptoms are not listed among the common side effects of tirzepatide in the UK product information, so in most cases another explanation is more likely. That said, a handful of indirect mechanisms could plausibly connect the two, and it is always worth telling your prescriber if something new appears after starting treatment. These are prescription-only medicines that require a clinical assessment before use, and a prescriber is best placed to weigh up what's happening in your specific situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The starting point is the product information itself. The NHS medicines page for tirzepatide lists the common and serious side effects of Mounjaro based on clinical trial data from thousands of adults across the SURMOUNT programme. Ear pressure, clogged ears and hearing changes do not appear in that list. The well-documented side effects are largely gastrointestinal: nausea, vomiting, diarrhoea, constipation and indigestion feature regularly, particularly in the early weeks of treatment or after a dose step-up.
That absence matters because it shifts the probability. When a symptom is genuinely caused by a medicine, it tends to show up consistently across large trial populations. Clogged ears do not. So if you notice it, the medicine is not automatically the culprit, and it is worth running through the other candidates before drawing a line between them.
A quick practical check you can do in under a minute: sit quietly, swallow once and then gently yawn. If the pressure clears immediately, your Eustachian tube is functioning and the cause is likely transient, congestion, altitude change, or a minor cold rather than anything related to your treatment.
Three plausible but indirect routes are worth knowing about, because they help you describe the symptom accurately when you speak to someone.
First, rapid weight loss. Mounjaro produces meaningful reductions in body weight over time, as the NICE appraisal of tirzepatide (TA1026) documents. The Eustachian tube (the narrow canal connecting your middle ear to the back of your throat) sits in tissue that can change as fat redistributes around the head and neck. Some people who lose weight relatively quickly report a temporary change in how their ears feel, sometimes described as patulous Eustachian tube dysfunction, where the tube becomes slightly too open rather than too closed. The sensation is often worse when lying down and better when upright.
Second, nausea-related swallowing changes. When nausea is prominent, people swallow differently and less often, which can affect the normal pressure-equalising mechanism the Eustachian tube performs with each swallow. If you have noticed that your injection seems to stop working before your next dose is due, our page on what to do when Mounjaro wears off after 5 days explains why that pattern happens and what you can do about it.
Third, sinus and upper-respiratory effects. Some people on GLP-1 medicines report increased mucus production or post-nasal drip, which can back up and temporarily block the Eustachian tube opening. This is the kind of mechanism that tends to resolve on its own.
None of these makes clogged ears a confirmed Mounjaro effect; they simply show why the timing might feel coincidental. If you want to explore how Mounjaro affects the body more broadly, our tirzepatide overview covers the dual GIP and GLP-1 mechanism in full.
Most cases of transient ear pressure resolve without any intervention. A few situations mean you should get proper medical attention rather than waiting it out.
See your GP promptly if the clogged sensation has lasted more than two or three weeks without any improvement, if your hearing is noticeably reduced on one or both sides, if you have pain alongside the pressure (our page on Mounjaro and ear pain covers that symptom specifically), if you hear a ringing or buzzing sound, or if you have dizziness or balance problems alongside the ear symptom.
These features suggest something beyond a routine pressure change, and they warrant examination. Your prescriber or GP can look at the eardrum directly and rule out fluid, infection or Eustachian tube dysfunction that might need treatment in its own right.
It is also sensible to mention any new symptom to your Mounjaro prescriber at your next review, and this is especially true if you are managing other health conditions alongside your weight-loss treatment, since our page on Mounjaro and ED shows how the medicine can interact with concerns that patients sometimes feel uncertain about raising. Patients can also flag unexpected side effects directly to the MHRA via the Yellow Card scheme, something our clinical team actively encourages. If you ever notice symptoms such as leg swelling, chest pain or breathlessness during treatment, it is worth reading our guidance on Mounjaro and blood clot risk so you know which signs need urgent attention.
If you are considering starting Mounjaro and already live with Eustachian tube issues, sinus problems or a history of ear conditions, that is useful information for a prescriber to have before treatment begins. It will not automatically rule you out, but it helps shape expectations and sets a sensible baseline.
If you are already on treatment and the ear symptom appeared in the first few weeks, it is worth documenting when it started, whether it coincided with a dose change, and what makes it better or worse. That detail makes a prescriber's assessment much more useful.
Prescription weight-loss treatment is a clinical relationship, not just a medicine in a box. If you have questions about starting or continuing Mounjaro, starting a free consultation with our prescribers is the straightforward next step. On the cost side, our Mounjaro price guide explains what private treatment typically includes in the UK. Our clinical team reviews every consultation personally, a named GPhC-registered prescriber reads your answers, not an automated system.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.